Drug Catalog - Product Detail
DESONIDE OINT 0.05% 60 GM
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 61748-0470-60 | AKORN | 60 | 0.05% | NA |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Desonide ointment, 0.05% contains desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11β,16α)) a synthetic corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primary synthetic steroids used topically as anti-inflammatory and antipruritic agents. Chemically, desonide, the active ingredient in desonide ointment, 0.05% is C 24 H 32 O 6 . It has the following structural formula: The molecular weight of desonide is 416.51. It is white to off-white powder. The solubility of desonide in distilled water saturated with the ether is 184 mg/L. Each gram of desonide ointment, 0.05% contains 0.5 milligram of desonide microdispersed in a base of white petrolatum. Chemical Structure
How Supplied
HOW SUPPLIED Desonide Ointment, 0.05% is available as follows: 15 g tube (NDC 61748-470-15) 60 g tube (NDC 61748-470-60)
Indications & Usage
INDICATIONS AND USAGE Desonide ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.
Dosage and Administration
DOSAGE AND ADMINISTRATION Desonide ointment, 0.05% should be applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary. Desonide ointment, 0.05% should not be used with occlusive dressings.